Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Nuc-3073
1. Nuc-3373
2. 1332837-31-6
3. 4yo6qt3sz9
4. Cpf-373
5. Nuc-3073
6. Fosifloxuridine Nafalbenamide [usan]
7. Benzyl (2s)-2-[[[(2r,3s,5r)-5-(5-fluoro-2,4-dioxopyrimidin-1-yl)-3-hydroxyoxolan-2-yl]methoxy-naphthalen-1-yloxyphosphoryl]amino]propanoate
8. Unii-4yo6qt3sz9
9. Chembl2181367
10. Ex-a4413
11. Who 10749
12. Db14859
13. Fosifloxuridine Nafalbenamide [inn]
14. Hy-109115
15. Cs-0078080
16. Fosifloxuridine Nafalbenamide [who-dd]
17. J3.616.613d
18. A936616
19. Benzyl N-[p-ambo-2'-deoxy-5-fluoro-p-(naphthalen-1-yl)-5'-uridyly]}-l-alaninate
20. L-alanine, N-(2'-deoxy-5-fluoro-p-1-naphthalenyl-5'-uridylyl)-, Phenylmethyl Ester
21. N-(2'-deoxy-5-fluoro-p-1-naphthalenyl-5'-uridylyl)-l-alanine Phenylmethyl Ester
22. Benzyl (2s)-2-{[{[(2r,3s,5r)-5-(5-fluoro-2,4-dioxo-3,4-dihydro-1(2h)-pyrimidinyl)-3-hydroxytetrahydro-2-furanyl]methoxy}(1-naphthyloxy)phosphoryl]amino}propanoate
23. L-alanine, N-(-2'-deoxy-2',2'-difluoro-p-1-naphthalenyl-5'-cytidylyl)-, Phenylmethyl Ester
| Molecular Weight | 613.5 g/mol |
|---|---|
| Molecular Formula | C29H29FN3O9P |
| XLogP3 | 3 |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 11 |
| Rotatable Bond Count | 12 |
| Exact Mass | 613.16254467 g/mol |
| Monoisotopic Mass | 613.16254467 g/mol |
| Topological Polar Surface Area | 153 Ų |
| Heavy Atom Count | 43 |
| Formal Charge | 0 |
| Complexity | 1100 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 4 |
| Undefined Atom Stereocenter Count | 1 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
A Fosifloxuridine Nafalbenamide manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Fosifloxuridine Nafalbenamide, including repackagers and relabelers. The FDA regulates Fosifloxuridine Nafalbenamide manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Fosifloxuridine Nafalbenamide API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Fosifloxuridine Nafalbenamide supplier is an individual or a company that provides Fosifloxuridine Nafalbenamide active pharmaceutical ingredient (API) or Fosifloxuridine Nafalbenamide finished formulations upon request. The Fosifloxuridine Nafalbenamide suppliers may include Fosifloxuridine Nafalbenamide API manufacturers, exporters, distributors and traders.
Fosifloxuridine Nafalbenamide Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Fosifloxuridine Nafalbenamide GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Fosifloxuridine Nafalbenamide GMP manufacturer or Fosifloxuridine Nafalbenamide GMP API supplier for your needs.
A Fosifloxuridine Nafalbenamide CoA (Certificate of Analysis) is a formal document that attests to Fosifloxuridine Nafalbenamide's compliance with Fosifloxuridine Nafalbenamide specifications and serves as a tool for batch-level quality control.
Fosifloxuridine Nafalbenamide CoA mostly includes findings from lab analyses of a specific batch. For each Fosifloxuridine Nafalbenamide CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Fosifloxuridine Nafalbenamide may be tested according to a variety of international standards, such as European Pharmacopoeia (Fosifloxuridine Nafalbenamide EP), Fosifloxuridine Nafalbenamide JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Fosifloxuridine Nafalbenamide USP).
LOOKING FOR A SUPPLIER?
